Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Cancer

Last data update: Mar 24, 2023. (Total: 58922 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 54 Records)

Next

Query Trace: Prostate Cancer[original query]>>Evidence Synthesis [Product Type]
Economic value of knowing BRCA status: BRCA testing for prostate cancer prevention and optimal treatment.
Oh Mok et al. Expert review of pharmacoeconomics & outcomes research 2023
Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence: The PET index.
Lindgren Belal Sarah et al. European journal of nuclear medicine and molecular imaging 2023
Prevalence of Germline BRCA1/2 Variants in Ashkenazi and Non-Ashkenazi Prostate Cancer Populations: A Systematic Review and Meta-Analysis.
Cioffi Antonio et al. Cancers 2023 15(1)
Analysis of a biopsy-based genomic classifier in high-risk prostate cancer: Meta-analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 phase III randomized trials.
Nguyen Paul L et al. International journal of radiation oncology, biology, physics 2023
Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention.
Seibert Tyler M et al. European urology 2023
Inference of core needle biopsy whole slide images requiring definitive therapy for prostate cancer.
Tsuneki Masayuki et al. BMC cancer 2023 23(1) 11
Prognostic Role of DNA Damage Response Genes Mutations and their Association With the Sensitivity of Olaparib in Prostate Cancer Patients.
Zhang Dong et al. Cancer control : journal of the Moffitt Cancer Center 2022 2910732748221129451
Cost-Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Cancer Treatment: A Systematic Review.
Chan Vivien Kin Yi et al. Frontiers in pharmacology 2022 13891149
Deciphering the Increased Prevalence of TP53 Mutations in Metastatic Prostate Cancer.
Zhang Wensheng et al. Cancer informatics 2022 2111769351221087046
Comparative performance of fully-automated and semi-automated artificial intelligence methods for the detection of clinically significant prostate cancer on MRI: a systematic review.
Sushentsev Nikita et al. Insights into imaging 2022 13(1) 59
Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups.
McHugh Jana et al. British journal of cancer 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1.
Palicelli Andrea et al. International journal of molecular sciences 2021 22(22)
Association of germline rare pathogenic mutations in guideline-recommended genes with prostate cancer progression: A meta-analysis.
Shi Zhuqing et al. The Prostate 2021
Prostate Cancer Risk Calculators for Healthy Populations: Systematic Review.
Bandala-Jacques Antonio et al. JMIR cancer 2021 7(3) e30430
Health Economic Evidence for Liquid- and Tissue-based Molecular Tests that Inform Decisions on Prostate Biopsies and Treatment of Localised Prostate Cancer: A Systematic Review.
Degeling Koen et al. European urology open science 2021 2777-87
Artificial Intelligence Compared to Radiologists for the Initial Diagnosis of Prostate Cancer on Magnetic Resonance Imaging: A Systematic Review and Recommendations for Future Studies.
Syer Tom et al. Cancers 2021 13(13)
Radiomic and Genomic Machine Learning Method Performance for Prostate Cancer Diagnosis: Systematic Literature Review.
Castaldo Rossana et al. Journal of medical Internet research 2021 23(4) e22394
Cost-Effectiveness of Genomic Test-Directed Olaparib for Metastatic Castration-Resistant Prostate Cancer.
Su Dan et al. Frontiers in pharmacology 2020 11610601
First-degree family history of prostate cancer is associated the risk of breast cancer and ovarian cancer.
Zheng QiongFei et al. Medicine 2021 Jan 100(4) e23816
A Systematic Review of Artificial Intelligence in Prostate Cancer.
Van Booven Derek J et al. Research and reports in urology 2021 1331-39
DNA damage repair gene mutation testing and genetic counseling in men with/without prostate cancer: a systematic review.
Armstrong Nigel et al. Future oncology (London, England) 2020 Dec
Deep Learning in Radiation Oncology Treatment Planning for Prostate Cancer: A Systematic Review.
Almeida Gonçalo et al. Journal of medical systems 2020 Aug 44(10) 179
Automated Classification of Significant Prostate Cancer on MRI: A Systematic Review on the Performance of Machine Learning Applications.
T Jose M Castillo et al. Cancers 2020 Jun 12(6)
Mainstream consent programs for genetic counseling in cancer patients: A systematic review.
Scheinberg Tahlia et al. Asia-Pacific journal of clinical oncology 2020 Apr
Prognostic value of the SPOP mutant genomic subclass in prostate cancer.
Shoag Jonathan et al. Urologic oncology 2020 Mar
Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study.
Callender Tom et al. PLoS medicine 2019 Dec 16(12) e1002998
Evaluation of New Tests and Interventions for Prostate Cancer Management: A Systematic Review.
Olleik Ghadeer et al. Journal of the National Comprehensive Cancer Network : JNCCN 2018 16(11) 1340-1351
CLINGEN Actionability Report for Acute Intermittent Porphyria - HMBS
ClinGen Actionability Working Group
CLINGEN Actionability Report for Hereditary Breast and Ovarian Cancer- BRCA1, BRCA2
ClinGen Actionability Working Group
CLINGEN Actionability Report for Lynch Syndrome - MLH1, MSH2, MSH6, PMS2, EPCAM
ClinGen Actionability Working Group
TOP